Top Markets
Coin of the day
Gelesis Holdings, Inc. Gelesis Holdings, Inc.

Gelesis Holdings, Inc.

GLS
Rang in Aktien #40695
Gelesis Holdings Inc. is a biopharmaceutical company actively marketing... Gelesis Holdings Inc. is a biopharmaceutical company actively marketing products, dedicated to creating biomimetic solutions that target the underlying causes of obesity and chronic gastrointestinal conditions. Among its key offerings is PLENITY, an oral therapeutic designed for weight management that is non-stimulant and does not enter the bloodstream. The company also provides an additional product for individuals who are overweight or obese, and its robust pipeline features potential treatments for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Established in 2006, Gelesis Holdings Inc. operates from its headquarters in Boston, Massachusetts.
Aktienkurs
$0.0121
Zuletzt synchronisiert: 2023-05-23
Marktkapitalisierung
$97.54K
Veränderung (1 Tag)
-24.38%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Gelesis Holdings, Inc. (GLS)

Kategorie

Dividendenrendite-Verlauf für Gelesis Holdings, Inc. (GLS)
Dividendenrendite (TTM) von Gelesis Holdings, Inc. (Aktienkürzel: GLS) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Gelesis Holdings, Inc. (GLS) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber